Antileishmanial Drug Discovery and Development: Time to Reset the Model?

Antileishmanial Drug Discovery and Development: Time to Reset the Model?

Leishmaniasis is a vector-borne parasitic disease caused by <i>Leishmania</i> species. The disease affects humans and animals, particularly dogs, provoking cutaneous, mucocutaneous, or visceral processes depending on the <i>Leishmania</i> sp. and the host immune response. No...

Full description

Bibliographic Details
Main Authors: Ana Isabel Olías-Molero, Concepción de la Fuente, Montserrat Cuquerella, Juan J. Torrado, José M. Alunda
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Microorganisms
Subjects:
leishmaniasis
visceral leishmaniasis
<i>Leishmania</i>
chemotherapy
drug discovery
drug pipeline
Online Access:https://www.mdpi.com/2076-2607/9/12/2500

Similar Items

Similar Items